Illaa Smesseim, longarts en arts-onderzoeker, NKI-AVL

Bio
Pulmonologist and PhD candidate

Presentation
Five decades ago a small experiment of two oncologist changed the way we treat cancer by giving rise to the current response evaluation criteria. In this presentation, we take the audience on a journey from that particular experiment to the emergence of Artificial Intelligence (AI) in the field of lung cancer. We will touch upon the ways AI can improve the way we measure tumors compared to the current RECIST criteria by automatically analyzing the entire tumor burden in each scan, giving a clear overview of the response to treatment to doctors and patients. With such a paradigm switch to volumetric followup, it might be time to think about new response criteria to guide treatment decisions..